APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 3mg capsule blister pack

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

rivastigmine hydrogen tartrate, Quantity: 4.8 mg

Dostopno od:

Arrotex Pharmaceuticals Pty Ltd

INN (mednarodno ime):

rivastigmine hydrogen tartrate

Farmacevtska oblika:

Capsule

Sestava:

Excipient Ingredients: iron oxide red; microcrystalline cellulose; Gelatin; iron oxide yellow; stearic acid; titanium dioxide; maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

Pot uporabe:

Oral

Enote v paketu:

14, 28, 112, 56

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

Rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type

Povzetek izdelek:

Visual Identification: Hard gelatine calsule with orange, opaque body and orange opaque cap. Imprinted "APO R3" in black ink, white to off white fill.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius

Status dovoljenje:

Licence status A

Datum dovoljenje:

2010-07-27